You can find the annual or quarterly income statement of Calidi Biotherapeutics Inc here for insights into the performance and operational efficiency of Calidi Biotherapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Total revenue

----

--0.00

-100.00%0.00

--0.00

--45.00K

--405.00K

Revenue

----

--0.00

-100.00%0.00

--0.00

--45.00K

--405.00K

Cost of revenue

----

--0.00

-100.00%0.00

--0.00

--14.00K

--50.00K

Operating expenses

-3.41%5.05M

-1.87%5.66M

-25.03%5.06M

-59.00%4.03M

-27.63%5.23M

-11.70%5.77M

24.71%6.75M

109.47%9.82M

3.36%7.22M

49.18%6.54M

-23.93%5.41M

44.65%4.69M

--6.99M

--4.38M

--7.12M

--3.24M

R&D expenses

9.66%2.36M

19.66%2.59M

-11.59%2.42M

-54.14%1.81M

-33.77%2.15M

-31.79%2.17M

4.61%2.74M

74.90%3.96M

67.15%3.25M

114.08%3.18M

67.54%2.62M

81.62%2.26M

--1.94M

--1.48M

--1.56M

--1.25M

Depreciation, depletion, and amortization

318.63%427.00K

610.00%710.00K

-1.96%100.00K

-1.01%98.00K

17.24%102.00K

-11.50%100.00K

9.68%102.00K

1.02%99.00K

40.32%87.00K

135.42%113.00K

78.85%93.00K

104.17%98.00K

--62.00K

--48.00K

--52.00K

--48.00K

Operating profit

3.41%-5.05M

1.87%-5.66M

25.03%-5.06M

59.00%-4.03M

27.63%-5.23M

11.70%-5.77M

-24.71%-6.75M

-109.47%-9.82M

-3.36%-7.22M

-49.18%-6.54M

23.44%-5.41M

-65.30%-4.69M

---6.99M

---4.38M

---7.07M

---2.84M

Net non-operating interest income (expenses)

Non-operating interest expense

-82.33%41.00K

-80.95%52.00K

-71.54%72.00K

-21.17%175.00K

-28.40%232.00K

-10.78%273.00K

16.59%253.00K

126.53%222.00K

1017.24%324.00K

1600.00%306.00K

1569.23%217.00K

58.06%98.00K

--29.00K

--18.00K

--13.00K

--62.00K

Special income (expenses)

-126.32%-100.00K

-120.00%-19.00K

117.59%35.00K

-96.07%48.00K

-92.16%380.00K

102.47%95.00K

86.85%-199.00K

141.22%1.22M

192.52%4.85M

-2189.88%-3.85M

-131.35%-1.51M

-398.32%-2.96M

--1.66M

---168.00K

---654.00K

---594.00K

Other non-operating income (expenses)

125.00%18.00K

-111.52%-22.00K

335.29%40.00K

-98.64%8.00K

-98.83%8.00K

110.57%191.00K

-102.48%-17.00K

4638.46%590.00K

17025.00%685.00K

-60333.33%-1.81M

68500.00%686.00K

-316.67%-13.00K

--4.00K

--3.00K

--1.00K

--6.00K

Income before tax

-1.99%-5.17M

0.03%-5.76M

29.94%-5.06M

49.65%-4.14M

-151.86%-5.07M

53.92%-5.76M

-11.81%-7.22M

-6.10%-8.23M

62.40%-2.01M

-173.76%-12.50M

16.54%-6.46M

-122.58%-7.76M

---5.35M

---4.56M

---7.74M

---3.49M

Income tax

1100.00%10.00K

-50.00%4.00K

-25.00%3.00K

200.00%3.00K

-109.09%-1.00K

100.00%8.00K

0.00%4.00K

0.00%-3.00K

1000.00%11.00K

-63.64%4.00K

100.00%4.00K

-200.00%-3.00K

--1.00K

--11.00K

--2.00K

--3.00K

Income after tax

-2.21%-5.18M

0.10%-5.76M

29.94%-5.06M

49.59%-4.15M

-150.44%-5.07M

53.87%-5.77M

-11.81%-7.22M

-6.10%-8.23M

62.20%-2.02M

-173.19%-12.50M

16.51%-6.46M

-122.30%-7.76M

---5.36M

---4.58M

---7.74M

---3.49M

Net income from continuous operations

-2.21%-5.18M

0.10%-5.76M

29.94%-5.06M

49.59%-4.15M

-150.44%-5.07M

53.87%-5.77M

-11.81%-7.22M

-6.10%-8.23M

62.20%-2.02M

-173.19%-12.50M

16.51%-6.46M

-122.30%-7.76M

---5.36M

---4.58M

---7.74M

---3.49M

Net Income attributable to non-controlling interests

-113.33%-32.00K

---46.00K

---76.00K

---51.00K

---15.00K

----

Net income attributable to controlling interests

-114.13%-10.82M

23.16%-5.71M

30.99%-4.99M

50.21%-4.10M

-149.70%-5.05M

40.50%-7.44M

-11.81%-7.22M

-6.10%-8.23M

62.20%-2.02M

-173.19%-12.50M

16.51%-6.46M

-122.30%-7.76M

---5.36M

---4.58M

---7.74M

---3.49M

Net income attributable to common shareholders

-114.13%-10.82M

23.16%-5.71M

30.99%-4.99M

50.21%-4.10M

-149.70%-5.05M

40.50%-7.44M

-11.81%-7.22M

-6.10%-8.23M

62.20%-2.02M

-173.19%-12.50M

16.51%-6.46M

-122.30%-7.76M

---5.36M

---4.58M

---7.74M

---3.49M

Basic earnings per share

-241.42%-2.21

85.77%-1.99

90.94%-0.18

82.57%-0.27

-45.06%-0.65

-407.57%-13.96

-42.94%-2.03

9.93%-1.54

62.21%-0.45

-173.18%-2.75

16.51%-1.42

-122.30%-1.71

---1.18

---1.01

---1.70

---0.77

Diluted earnings per share

-241.42%-2.21

85.77%-1.99

90.94%-0.18

82.57%-0.27

-45.06%-0.65

-407.57%-13.96

-42.94%-2.03

9.93%-1.54

62.21%-0.45

-173.18%-2.75

16.51%-1.42

-122.30%-1.71

---1.18

---1.01

---1.70

---0.77

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

